
Advances in Surgery 2014
Description
Alles über E-Books | Antworten auf Fragen rund um E-Books, Kopierschutz und Dateiformate finden Sie in unserem Info- & Hilfebereich.
More details
Other editions
Additional editions

Content
- Front Cover
- Advances In Surgery
- Copyright
- Contributors
- Contents
- Follow or Repair?
- Introduction
- Incidence
- Cause and natural history
- Clinical presentation and diagnosis
- Economic impact
- Management
- Women
- Men
- Symptomatic inguinal hernias
- Asymptomatic/Minimally symptomatic inguinal hernias
- The North American trial
- UK trial
- Long-term results of the randomized controlled trials
- The North American hernia trial
- UK trial
- Comparison between the 2 trials and their long-term follow-up studies
- Summary
- References
- Is It Safe to Follow Side Branch IPMNs?
- Introduction
- Epidemiology
- Diagnosis of Bd-IPMN
- Transabdominal ultrasonography
- Contrast-enhanced CT scan
- MRI with MR cholangiopancreatography
- Endoscopic US with cystic fluid analysis and cytology
- Management of Bd-IPMN
- Validation of the international guidelines for the management of Bd-IPMN
- Summary
- References
- Endoscopic Myotomy for Achalasia
- Background
- Technique
- Efficacy
- POEM in the setting of prior achalasia treatments
- End-stage achalasia
- Achalasia subtypes
- Extended indications: nonachalasia neuromotor disorders
- Gastroesophageal reflux disease
- Comparison with Heller myotomy
- Summary
- References
- Can Interventionalists do Endovascular Aortic Aneurysm Repair As Well As Vascular Surgeons?
- Background
- Who should perform EVAR?
- Centers of excellence for AAA management and EVAR
- EVAR skills of surgeons and interventionalists
- Is there a role for multidisciplinary EVAR care?
- References
- Does Walking Speed Predict Postoperative Morbidity?
- Introduction
- Importance of preoperative risk assessment for the older adult
- History of preoperative risk assessment
- Preoperative assessment: frailty
- Walking speed alone reflects multidimensional frailty
- Slow walking speed predicts adverse health outcomes
- Walking speed predicts adverse surgical outcomes
- Practical ways to measure walking speed
- Future directions
- References
- Does Close Temperature Regulation Affect Surgical Site Infection Rates?
- Introduction
- Pathophysiology principles
- Increased total oxygen consumption and decreased peripheral perfusion
- Induced coagulopathy
- Reduced immune response
- Principles applied to surgical practice
- Evidence base of clinical practice
- Summary
- References
- The Utility of the Robot in Pancreatic Resections
- Introduction
- Distal pancreatectomy
- Outcomes
- Reduced conversion rate
- Improved ability to perform splenic preservation
- Reduction in EBL
- Oncologic outcomes
- Cost
- Specific steps where the robot offers technical improvement in distal pancreatectomy
- Division of the pancreatic neck
- Vascular dissection
- Lymphadenectomy
- RDP
- Outcomes
- Operative times
- Open conversion and blood loss
- Morbidity
- Pancreatic Fistula
- Specific steps where the robot offers technical improvement in minimally invasive pancreaticoduodenectomy
- Portal dissection
- Division of the pancreatic neck
- SMV/portal vein mobilization
- Uncinate dissection
- Reconstruction
- Pancreaticojejunostomy
- Hepaticojejunostomy
- Versatility of the robotic platform
- Dissemination
- Potential oncologic advantages to robotic pancreatic resections
- Summary
- References
- Current Treatment for Small (&5 cm) Hepatocellular Carcinoma
- Evolving Roles for Ablation and Resection
- Introduction
- Outcomes after resection
- Thermal ablation
- RFA
- Resection versus RFA
- Resection and ablation
- Algorithm for care
- References
- Screening for Pancreatic Cancer
- Background
- The need for pancreatic cancer screening
- Benefit of early detection in other common cancers
- Potential difficulties with early detection screening
- Problems related to lead-time and length bias
- Problems related to screening test accuracy
- Who and how to screen?
- Groups at high risk of pancreatic adenocarcinoma
- High-risk premalignant lesions: PanINs and IPMNs
- Early mutations in pancreatic cancer development
- Screening tools for pancreatic cancer
- Current biomarkers for pancreatic cancer
- Potential novel biomarkers for pancreatic cancer
- Role of imaging in screening for pancreatic cancer
- Opportunities for prevention
- Practitioners and early detection
- Summary
- References
- Tissue Engineering
- Introduction
- Methods in tissue engineering
- Cells
- Biomaterials and scaffolds
- Vascularization
- Bioengineered constructs in surgery
- Skin
- Hollow structures: vessels, upper airways, and lower urinary tract
- Solid organs: the next frontier
- Heart
- Liver
- Kidney
- Pancreas
- Summary
- References
- Early Versus Delayed Surgery
- Introduction
- Pathogenesis
- Clinical manifestation
- Imaging
- Severity of acute cholecystitis and treatment
- Timing of cholecystectomy
- Open versus laparoscopic cholecystectomy
- Summary
- Acknowledgments
- References
- Gastrointestinal Stromal Tumors
- Who Should Get Imatinib and for How Long?
- Introduction
- Oncogenic kinase mutations and imatinib
- Metastatic GIST and imatinib
- Is imatinib effective in metastatic GIST?
- What is the optimal initial dosing scheme in metastatic GIST?
- Is higher-dose imatinib ever appropriate as first-line therapy?
- How is response to therapy optimally assessed?
- Does the type of mutation affect prognosis in advanced GIST?
- How long does imatinib treatment continue?
- Is there a role for surgery in metastatic patients treated with imatinib?
- What is appropriate therapy with evidence of disease progression?
- What is second-line therapy for patients progressing on imatinib?
- What agents are under investigation for imatinib-refractory GIST?
- Imatinib as adjuvant therapy
- Who is at greatest risk for recurrence following resection?
- Does adjuvant imatinib prolong RFS or OS compared with placebo?
- Do all patients benefit from adjuvant imatinib?
- Is a longer duration of adjuvant treatment beneficial?
- Does adjuvant imatinib affect development of imatinib resistance?
- Is salvage imatinib following recurrence effective?
- When is neoadjuvant imatinib indicated?
- Summary
- References
- Readmission After Surgery
- Introduction
- Readmission after medical and surgical hospitalization
- Defining and measuring readmission
- Hospital Readmissions Reduction Program
- Statistical issues for hospital profiling on readmission
- Predicting readmission
- Causes and prevention of readmission
- Summary
- References
- What Is Wrong with the Training of General Surgery?
- Key points
- Changes in surgical diseases
- Changes in operative technique
- Changes in management of certain disease processes
- Trauma
- Outpatient surgery
- Changes in work hours
- Changes in supervision and documentation
- Changes in resident expectations
- Lack of mentorship
- Improving general surgery training
- Summary
- References
- Aspirin, Clopidogrel, and the Surgeon
- Introduction
- Aspirin and thienopyridines
- Indications for antiplatelet therapy
- Consequences of cessation of antiplatelet therapy
- Current guideline recommendations regarding antiplatelet use and timing of surgery
- Summary
- References
- Islet Autotransplantation and Total Pancreatectomy
- Introduction
- Total pancreatectomy and the introduction of IAT
- Patient selection
- Surgical approach
- Pancreatectomy
- Pancreas processing
- Islet infusion
- Early postoperative glycemic management
- Results of total pancreatectomy with IAT
- Relief of pain
- Endocrine function
- Quality of life
- Special considerations
- Pediatric patients
- Malignancy
- Future directions
- Summary
- References
- Liver Transplantation for Metastatic Neuroendocrine Tumors
- Key points
- Epidemiology and background
- Classification
- Presentation
- Diagnosis
- Hormone activity
- Tumor histopathology
- Imaging
- Clinical management
- Resectable metastatic lesions
- Unresectable metastatic lesions
- Locoregional therapies
- Systemic therapies
- Surgical palliation
- Liver transplantation
- Patient selection for transplantation
- Timing of LT
- Prognosis: outcomes of LT
- Current practice in the United States
- Summary
- References
- Irreversible Electroporation
- A Novel Therapy for Stage III Pancreatic Cancer
- Background
- Mechanism of action
- Patient selection
- Technique
- Safety
- Efficacy
- Further investigation
- References
- Index
System requirements
File format: ePUB
Copy protection: Adobe-DRM (Digital Rights Management)
System requirements:
- Computer (Windows; MacOS X; Linux): Install the free reader Adobe Digital Editions prior to download (see eBook Help).
- Tablet/smartphone (Android; iOS): Install the free app Adobe Digital Editions or the app PocketBook before downloading (see eBook Help).
- E-reader: Bookeen, Kobo, Pocketbook, Sony, Tolino and many more (not Kindle).
The file format ePub works well for novels and non-fiction books – i.e., „flowing” text without complex layout. On an e-reader or smartphone, line and page breaks automatically adjust to fit the small displays.
This eBook uses Adobe-DRM, a „hard” copy protection. If the necessary requirements are not met, unfortunately you will not be able to open the eBook. You will therefore need to prepare your reading hardware before downloading.
Please note: We strongly recommend that you authorise using your personal Adobe ID after installation of any reading software.
For more information, see our ebook Help page.